Cargando…

Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors

Use of Cannabis, the most widely used illicit drug worldwide, is associated with acute anxiety, and anxiety disorders following regular use. The precise neural and receptor basis of these effects have not been tested in man. Employing a combination of functional MRI (fMRI) and positron emission tomo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhattacharyya, Sagnik, Egerton, Alice, Kim, Euitae, Rosso, Lula, Riano Barros, Daniela, Hammers, Alexander, Brammer, Michael, Turkheimer, Federico E., Howes, Oliver D., McGuire, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670208/ https://www.ncbi.nlm.nih.gov/pubmed/29101333 http://dx.doi.org/10.1038/s41598-017-14203-4

Ejemplares similares

Epigenetic Mediation of AKT1 rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing
por: Blest-Hopley, Grace, et al.
Publicado: (2021)

S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE
por: Colizzi, Marco, et al.
Publicado: (2018)

Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans
por: Colizzi, Marco, et al.
Publicado: (2019)

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
por: Colizzi, Marco, et al.
Publicado: (2019)

Test–retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [(11)C]MePPEP
por: Riaño Barros, Daniela A., et al.
Publicado: (2014)

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
por: Colizzi, Marco, et al.
Publicado: (2017)

Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB(1) and Serotonin 5-HT(2A) Receptors
por: Viñals, Xavier, et al.
Publicado: (2015)

Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells
por: Yang, Lei, et al.
Publicado: (2015)

Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study
por: Chung, Hery, et al.
Publicado: (2019)

Adulteration of low‐delta‐9‐tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services
por: Monti, Manuela Carla, et al.
Publicado: (2022)

Cannabinoid CB1 receptors regulate salivation
por: Andreis, Kelsey, et al.
Publicado: (2022)

Voltage dependence of the cannabinoid CB1 receptor
por: Goldberger, Esty, et al.
Publicado: (2022)

The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation
por: Bow, Eric W., et al.
Publicado: (2016)

Hippocampal CB(1) receptors mediate the memory impairing effects of Δ(9)-tetrahydrocannabinol
por: Wise, Laura E., et al.
Publicado: (2009)

Delta-8 Tetrahydrocannabinol Product Impurities
por: Ray, Colleen L., et al.
Publicado: (2022)

Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells
por: Jiang, Shuxian, et al.
Publicado: (2007)

Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors
por: Dutta, Soumajit, et al.
Publicado: (2022)

Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys
por: Bouskila, Joseph, et al.
Publicado: (2016)

CB1 Cannabinoid Receptor Signaling and Biased Signaling
por: Leo, Luciana M., et al.
Publicado: (2021)

Cannabinoids, reward processing, and psychosis
por: Gunasekera, Brandon, et al.
Publicado: (2021)

Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2
por: Xie, Junran, et al.
Publicado: (2016)

Effects of pro‐inflammatory cytokines on cannabinoid CB (1) and CB (2) receptors in immune cells
por: Jean‐Gilles, L., et al.
Publicado: (2015)

Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
por: Soderstrom, Ken, et al.
Publicado: (2017)

Cannabinoid(1) (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose
por: Skolnick, Phil, et al.
Publicado: (2019)

Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB(1)) Receptor
por: Horváth, Viktória B., et al.
Publicado: (2021)

Loss of Cannabinoid Receptor CB1 Induces Preterm Birth
por: Wang, Haibin, et al.
Publicado: (2008)

Increased Expression of Cannabinoid CB(1) Receptors in Achilles Tendinosis
por: Björklund, Emmelie, et al.
Publicado: (2011)

Cannabinoid CB(1) Receptors Mediate the Gastroprotective Effect of Neurotensin
por: Hassanzadeh, Parichehr, et al.
Publicado: (2012)

Cardiorespiratory Anomalies in Mice Lacking CB(1) Cannabinoid Receptors
por: Silvani, Alessandro, et al.
Publicado: (2014)

THC Regulates Tearing via Cannabinoid CB1 Receptors
por: Thayer, Amanda, et al.
Publicado: (2020)

PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
por: Gardner, Eliot L., et al.
Publicado: (2016)

Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint
por: Zamith Cunha, Rodrigo, et al.
Publicado: (2023)

Test-retest reproducibility of quantitative binding measures of [(11)C]Ro15-4513, a PET ligand for GABA(A) receptors containing alpha5 subunits
por: McGinnity, Colm J., et al.
Publicado: (2017)

An Update on Non-CB(1), Non-CB(2) Cannabinoid Related G-Protein-Coupled Receptors
por: Morales, Paula, et al.
Publicado: (2017)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
por: Ibsen, Mikkel Søes, et al.
Publicado: (2019)

Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB(1)/CB(2) Receptor Interaction
por: Asproni, Battistina, et al.
Publicado: (2021)

Neuroimaging Evidence for Cannabinoid Modulation of Cognition and Affect in Man
por: Bhattacharyya, Sagnik, et al.
Publicado: (2012)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9u8snn13le7pgk57mbvte668k2